
Averride M 2mg/500mg Tablet SR
Marketer
Altrawell Biotech Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Averride M 2mg/500mg Tablet SR
Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and potentially serious complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, incorporating dietary changes, regular exercise, and weight management as advised by your doctor. Lifestyle modifications are integral to successful diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Familiarize yourself with its symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures, such as readily available glucose sources like candy or juice. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnancy and lactation necessitate consultation with your doctor before initiating treatment. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be required.
Uses of Averride M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Averride M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or break it. Consume Averride M 2mg/500mg Extended-Release tablets with food.
Common Side effects of Averride M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Averride M 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; do not chew, crush, or fracture it. Averride M 2mg/500mg Extended-Release tablets should be taken with a meal.
How Averride M 2mg/500mg Tablet SR works:
Averride M 2mg/500mg Tablet SR is a combination of two antidiabetic medicines: Glimepiride and Metformin.Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
SAFETY ADVICE
AlcoholUNSAFE
Combining Averride M 2mg/500mg SR tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Using Averride M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Sustained-release Averride M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Averride M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Averride M 2mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Averride M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, Averride M 2mg/500mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Averride M 2mg/500mg Tablet SR :
Should you forget to take your Averride M 2mg/500mg SR Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Averride M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Diabetes medication |
